Streetbeat News

Analyst Ratings

GMS

Raymond James analyst Joshua Wilson maintains an Outperform rating on GMS (NYSE:GMS) and raises the price target from $70 to $82.

Portfolio Pulse from richadhand@benzinga.com

June 23, 2023 | 11:44 am

DRI

Darden Restaurants reported mixed Q4 results with sales growth of 6.4% YoY to $2.769 billion, slightly missing the consensus of $2.77 billion. EPS of $2.58 beat the consensus of $2.54. The company expects FY24 sales of $11.5 billion - $11.6 billion and adjusted EPS of $8.55 - $8.85. Following the announcement, TD Cowen and Wedbush raised their price targets on DRI.

Portfolio Pulse from Lisa Levin

June 23, 2023 | 11:39 am

ACN

Accenture reported Q3 FY23 revenue growth of 3% YoY to $16.57 billion, slightly beating the consensus of $16.56 billion. Adjusted EPS of $3.19 beat the consensus of $3.04. However, analysts from Piper Sandler and TD Cowen cut their price targets on Accenture following the earnings announcement.

Portfolio Pulse from Lisa Levin

June 23, 2023 | 11:34 am

TSLA

In a CNBC interview, billionaire investor Ron Baron stated that he expects Tesla's stock price to reach $500 per share by 2025.

Portfolio Pulse from Charles Gross

June 23, 2023 | 11:15 am

BLK

BTCUSD

Crypto analyst DonAlt believes that Bitcoin could break past the $32,000 resistance level, thanks to BlackRock's filing for a spot Bitcoin ETF. He is confident that the news ensures more upside potential than downside for Bitcoin.

Portfolio Pulse from Mehab Qureshi

June 23, 2023 | 10:48 am

W

MoffettNathanson analyst Michael Morton has upgraded Wayfair (NYSE:W) from Underperform to Market Perform and announced a $44 price target.

Portfolio Pulse from richadhand@benzinga.com

June 23, 2023 | 10:45 am

DRI

Wedbush analyst Nick Setyan maintains an Outperform rating on Darden Restaurants (NYSE:DRI) and raises the price target from $175 to $178.

Portfolio Pulse from richadhand@benzinga.com

June 23, 2023 | 10:41 am

ZUO

Needham analyst Joshua Reilly reiterated a Buy rating on Zuora (NYSE:ZUO) and maintained a $15 price target.

Portfolio Pulse from richadhand@benzinga.com

June 23, 2023 | 10:40 am

ROIV

HC Wainwright & Co. analyst Douglas Tsao reiterates a Buy rating on Roivant Sciences (NASDAQ:ROIV) and maintains a $15 price target.

Portfolio Pulse from richadhand@benzinga.com

June 23, 2023 | 10:13 am

IVVD

HC Wainwright & Co. analyst Patrick Trucchio reiterated a Buy rating on Invivyd (NASDAQ:IVVD) and maintained a $5 price target.

Portfolio Pulse from richadhand@benzinga.com

June 23, 2023 | 10:12 am